Skip to main content
logo
Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 29, 2026, 10:17 AM EST

Regen BioPharma Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
011633130
Market Cap Growth
-97.80%-48.33%-83.75%-80.65%-74.88%59229.10%
Enterprise Value
122734132
Last Close Price
0.000.010.100.904.8822.82

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PE Ratio
---6.1814.69-
PS Ratio
0.242.254.3526.75138.87760.54
PB Ratio
-0.01-0.08-0.20-1.24-4.07-9.65

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
4.366.627.1329.34145.32773.60

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
-0.18-0.19-0.15-0.15-0.16-0.27
Net Debt / Equity Ratio
-0.18-0.18-0.15-0.12-0.15-0.21
Asset Turnover
1.101.090.920.520.270.26
Quick Ratio
0.050.040.020.020.040.06
Current Ratio
0.050.040.030.030.040.07
Return on Assets (ROA)
-252.85%-97.12%-101.33%-94.09%-23.97%-18.79%
Return on Capital Employed (ROCE)
16.20%5.40%8.00%13.90%4.20%1.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-1273.56%-239.77%-64.96%18.27%7.47%-5.20%
Buyback Yield / Dilution
-507.33%-186.14%-16.21%-12.79%-56.19%-113.61%